Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Number of items: 12.

Gee, Julia M. ORCID: https://orcid.org/0000-0001-6483-2015, Meng, Mei Yee, McClelland, Richard A., Mottram, Huw J., Kyme, Susan R., Finlay, Pauline, Goddard, Lindy, Dutkowski, Carol M., Barrow, Denise, Parson, Walther and Fiegl, Heidi 2015. A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research 75 (9) , P3-05-19.
file

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Goddard, Lindy, Mottram, Huw James, Burmi, Rajpal, Pumford, Sara L., Dutkowski, Carol M., Barrow, Denise, Hutcheson, Iain Robert, Nicholson, Robert Ian, Ellis, Ian O. and Elvin, Paul 2014. Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research 74 (19) , 738. 10.1158/1538-7445.AM2014-738
file

Lazaro, Glorianne, Smith, Chris, Goddard, Lindy, Jordan, Nicola Jane, McClelland, Richard Andrew, Barrett-Lee, Peter, Nicholson, Robert Ian and Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 2013. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Endocrine Related Cancer 20 (5) , pp. 691-704. 10.1530/ERC-13-0019

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Baruha, Bedanta, Smith, Chris, Bellerby, Rebecca, Goddard, Lindy, Jordan, Nicola Jane, Poghosyan, Zaruhi ORCID: https://orcid.org/0000-0003-4966-7618, Nicholson, Robert Ian, Barrett-Lee, Peter and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12 , 458. 10.1186/1471-2407-12-458
file

Hutcheson, Iain Robert, Goddard, Lindy, Barrow, Denise, McClelland, Richard Andrew, Francies, Hayley E., Knowlden, Janice Mary, Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2011. Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1. Breast Cancer Research 13 (2) , R29. 10.1186/bcr2848
file

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Nicholson, Robert Ian, Barrow, Denise, Dutkowski, Carol Mary, Goddard, Lindy, Jordan, Nicola J., McClelland, Richard Andrew, Knowlden, Janice Mary, Francies, Hayley E., Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 and Hutcheson, Iain Robert 2011. Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Hormone Molecular Biology and Clinical Investigation 5 (2) , pp. 67-77. 10.1515/HMBCI.2011.009

Hutcheson, Iain Robert, Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Barrow, Denise and Nicholson, Robert Ian 2010. Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins [Abstract]. Breast Cancer Research 12 (S1) , P13. 10.1186/bcr2510
file

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Smith, Christopher, Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert 2009. Adverse features of acquired antihormone resistance and their targeting. Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert, eds. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets, London: Springer, pp. 139-160. (10.1007/978-1-4020-8526-0_8)

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Goddard, Lindy, Jordan, Nicola Jane, Smith, Chris, Harper, Maureen Elaine, Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2008. Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1 [Abstract]. Breast Cancer Research 10 (S2) , P34. 10.1186/bcr1918
file

Jones, Helen E., Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Rubini, M., Barrow, Denise, Knowlden, Janice Mary, Williams, Sophie E., Wakeling, A. E. and Nicholson, Robert Ian 2004. Insulin-like growth factor-1 receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocrine-Related Cancer 11 (4) , pp. 793-814. 10.1677/erc.1.00799

Jones, Helen E., Barrow, Denise, Dutkowski, Carol, Goddard, Lindy, Smith, Christopher, Harper, Maureen E. and Nicholson, Robert Ian 2001. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: Identification of divergent growth regulatory pathways. The Prostate 49 (1) , pp. 38-47. 10.1002/pros.1116

Hepburn, P. J., Glynne-Jones, E., Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Harper, Maureen Elaine 1995. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA. Histochemical Journal 27 (3) , pp. 196-203. 10.1007/BF00177586

This list was generated on Fri May 3 14:17:14 2024 BST.